● Live Tracking 375+ pre-IPO companies with institutional-grade data — updated daily. 140 in active pipeline.

Neuralink IPO Status 2026

Brain-computer interface company developing implantable chips (Telepathy device). Raised $650M Series E at $9B valuation (June 2025). CEO Elon Musk has no IPO plans — company is focused on FDA clinical trials, not public markets.

IndustryHealthcare Technology
StageSeries E
IPO StatusPrivate
Valuation$9.7B
Total Funding$1.3B
HeadquartersAustin, TX
CEODJ Seo
How to Invest in Neuralink
Pre-IPO
🔔 Get Notified When Neuralink IPOs

No secondary market access for Neuralink yet. Get instant alerts when an S-1 is filed or IPO date is announced.

Get IPO Alerts →
📡 IPO Intelligence
$49/mo — Unlimited Reports + Real-Time Updates
⚡Unlimited company analysis reports — all 375+ companies
✓Real-time IPO alerts — know the moment S-1s are filed
✓Verified data updated daily — not chatbot hallucinations
💡 Tracking multiple companies? Full access pays for itself after 3 reports.
$49
per month
Subscribe Now →
Cancel anytime · Secure via Stripe
Institutional Research
$19 — Get the Complete Neuralink Analysis Brief
✓Executive summary & IPO readiness breakdown
✓Competitive positioning & funding trajectory
✓Bull / bear thesis with pricing projections
✓S-1 timeline estimate & risk assessment
$19
One-time
Secure checkout · Stripe · 24h delivery

Frequently Asked Questions

What is Neuralink's current valuation? +

Neuralink is valued at $9.7B as of the most recent funding round.

How much total funding has Neuralink raised? +

Neuralink has raised $1.3B in total venture capital funding.

What sector is Neuralink in? +

Neuralink is a Healthcare Technology company. Brain-computer interface company developing implantable chips (Telepathy device). Raised $650M Serie.

What is Neuralink's IPO readiness score? +

Neuralink scores 63/100 on TechStackIPO's IPO readiness index, which evaluates funding stage, valuation trajectory, S-1 filing status, and market timing signals.